ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,99
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,135
-0,59%
Bitcoin
61 720,28
4,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) Actualités

SEEL Seelos Therapeutics Inc

0,3474
0,0174 (5,27%)
Dernière mise à jour : 18:47:32
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Seelos Therapeutics Inc SEEL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0174 5,27% 0,3474 18:47:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,342 0,33 0,354 0,33
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/3/202423:32EDGAR2Form S-1/A - General form for registration of securities..
06/3/202422:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:50EDGAR2Form D - Notice of Exempt Offering of Securities
06/2/202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202412:04EDGAR2Form S-1 - General form for registration of securities under..
30/1/202422:01EDGAR2Form 8-K - Current report
30/1/202412:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202414:05EDGAR2Form 8-K - Current report
18/1/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:16EDGAR2Form 8-K - Current report
09/1/202403:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202322:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202314:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202322:59EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202322:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/12/202322:54EDGAR2Form S-3 - Registration statement under Securities Act of..
15/12/202322:06EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
01/12/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:08EDGAR2Form 8-K - Current report
30/11/202322:59EDGAR2Form 8-K - Current report
30/11/202322:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202322:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202322:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/11/202315:00EDGAR2Form 8-K - Current report
24/11/202318:07EDGAR2Form 8-K - Current report
24/11/202317:10EDGAR2Form 8-K - Current report
03/11/202321:15EDGAR2Form 8-K - Current report
02/10/202312:03EDGAR2Form 8-K - Current report
29/9/202322:56EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/9/202322:06EDGAR2Form 8-K - Current report
25/9/202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/9/202313:00EDGAR2Form 8-K - Current report
15/9/202322:01EDGAR2Form S-3 - Registration statement under Securities Act of..
14/9/202315:00EDGAR2Form 8-K - Current report
01/9/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/6/202315:00EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
SEEL
Seelos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés